Intraocular pressure response to medication in a clinical setting: The marshfield clinic personalized medicine research project

Journal of Glaucoma

Volumn 17, Issue 5, 2008, Pages 372-377

  McCarty, Catherine A ^a   Mukesh, Bickol N ^a   Kitchner, Terrie E ^a   Hubbard, William C ^a   Wilke, Russell A ^a   Burmester, James K ^a   Patchett, Richard B ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Epidemiology; Glaucoma; Health services research; Ocular hypertension; Treatment outcome

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBONATE DEHYDRATASE INHIBITOR; CHOLINERGIC RECEPTOR STIMULATING AGENT; PROSTAGLANDIN DERIVATIVE; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG COMPETITION; DRUG EFFICACY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; OPEN ANGLE GLAUCOMA; PATIENT COMPLIANCE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRABECULECTOMY; TRABECULOPLASTY; TREATMENT RESPONSE; ADOLESCENT; AGE DISTRIBUTION; DRUG EFFECT; DRUG USE; HEALTH SERVICES RESEARCH; MIDDLE AGED; SEX RATIO; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DRUG UTILIZATION REVIEW; FEMALE; GLAUCOMA, OPEN-ANGLE; HEALTH SERVICES RESEARCH; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PREVALENCE; SEX DISTRIBUTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 58149130291     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31815c5f3f     Document Type: Article

References (16)

1. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
2. Eye Diseases Prevalence Research Group. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.
3. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.
4. Schoff EO, Hattenhauer MG, Ing HH, et al. Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota. Ophthalmology. 2001;108:882-886.
5. Wang F, Javitt JC, Tielsch JM. Racial variations in treatment for glaucoma and cataract among Medicare recipients. Ophthalmic Epidemiol. 1997;4:89-100.
6. Glynn RJ, Gurwitz JH, Bohn RL, et al. Old age and race as determinants of initiation of glaucoma therapy. Am J Epidemiol. 1993;138:395-406.
7. Friedman DS, Nordstrom B, Mozaffari E, et al. Variations in treatment among adult-onset open-angle glaucoma patients. Ophthalmology. 2005;112:1494-1499.
8. Owen CG, Carey IM, de Wilde S, et al. The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003. Br J Ophthalmol. 2006;90:861-868.
9. McCarty CA, Wilke RA, Giampietro PF, et al. Marshfield clinic personalized medicine research project (PMRP): design, methods and recruitment for a large population-based biobank. Personalized Med. 2005;2:49-79.
10. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study. A randomized trial determines that topical hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120: 701-713.
11. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressure. Am J Ophthalmol. 1998;126:487-497.
12. The European Glaucoma Prevention Study (EGPS) Group. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112:366-375.
13. Weih LM, Van Newkirk M, McCarty CA, et al. Patterns of glaucoma medication use in urban and rural Victoria. Aust NZ J Ophthalmol. 1998;26:S12-S15.
14. Van der Valk R, Schouten JSAG, Webers CAB, et al. Changes in glaucoma treatment and achieved IOP after introduction of new glaucoma medication. Graefe's Arch Clin Exp Ophthalmol. 2006;244: 1267-1272.
15. Orme M, Boler A. Prostaglandin analogues for the treatment of glaucoma and ocular hypertension. A systematic review of economic evidence. Pharmacoeconomics. 2006;24:743-750.
16. DeStefano F, Eaker ED, Broste SK, et al. Epidemiologic research in an integrated regional medical care system: the Marshfield epidemiologic study area. J Clin Epidemiol. 1996;49:643-652.